This change will take effect March 2, 2015
Overview and Clinical Utility:
Effective March 2, 2015, PathGroup will begin screening for Oxycodone within the Drugs of Abuse 10 Panel Screen (UDSL) and Urine Drug Screen with Reflex to Confirmation (UDSC). As currently allowed, each component of the urine drug screen may be ordered as a standalone test.
Click Here to read more.